Remove Aortic Remove Article Remove Thrombosis
article thumbnail

JACC Topic of the Week Review Details Pharmacotherapy Algorithm For TAV Thrombosis

American College of Cardiology

For the treatment of transcatheter aortic valve (TAV) thrombosis, both in its more common form of subclinical leaflet thrombosis (SLT) and the rarer clinical valve thrombosis (CVT), pharmacotherapy with vitamin K antagonists (VKA), non-vitamin K oral anticoagulants (NOAC) and an ultraslow, low-dose infusion of thrombolytics should be considered as (..)

article thumbnail

TAVI Matches SAVR in Lower Risk Aortic Valve Patients: 10 year outcomes

Cardiology Update

The NOTION trial, a pioneering study, sought to compare the long-term clinical and bioprosthesis outcomes of Transcatheter Aortic Valve Implantation (TAVI) versus Surgical Aortic Valve Replacement (SAVR) in patients with severe aortic valve stenosis (AS) at lower surgical risk. Original article: Thyregod HGH et al.

article thumbnail

Ballooning an obstructed prosthetic Aortic valve : Can be a real tense procedure!

Dr. S. Venkatesan MD

A 76-year-old woman with a history of double valve replacement (Aortic and mitral valves) for rheumatic heart disease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. The investigations revealed a stuck aortic prosthetic valve ,that showed a prohibitive gradient of more than 50 mmhg.

article thumbnail

Role of Left Ventricular Ejection Fraction in Modern High-Risk PCI with pLVAD Support

Cardiology Update

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization. Am Heart J.

article thumbnail

Lifelong risk of stroke after TAVR: Findings from SwissTAVI Registry

Cardiology Update

Within the realm of transcatheter aortic valve replacement (TAVR), stroke emerges as a recognized adverse event, manifesting at various stages during and after the procedure. Original article: Okuno et al. Previous studies extensively delved into short-term incidence, trends, and clinical outcomes related to TAVR-associated stroke.

TAVR 111